A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Year: 2009
Type: article
Study design: Observational Study
Source: Nature Genetics
DOI: 10.1038/ng.424
Authors: Australian Cancer (Ovarian) Study, Honglin Song, The Australian Ovarian Cancer Study Group, Susan J Ramus, Jonathan Tyrer, Kelly L Bolton, Aleksandra Gentry-Maharaj, Eva Wozniak, Hoda Anton-Culver, Jenny Chang-Claude, Daniel W Cramer, Richard DiCioccio, Thilo Dörk, Ellen L Goode, Marc T Goodman, Joellen M Schildkraut, Thomas Sellers, Laura Baglietto, Matthias W Beckmann, Jonathan Beesley, Jan Blaakaer, Michael E Carney, Stephen Chanock, Zhihua Chen, Julie M Cunningham, Ed Dicks, Jennifer A Doherty, Matthias Dürst, Arif B Ekici, David Fenstermacher, Brooke L Fridley, Graham Giles, Martin E Gore, Immaculata De Vivo, Peter Hillemanns, Claus Hogdall, Estrid Hogdall, Edwin S Iversen, Ian J Jacobs, Anna Jakubowska, Dong Li, Jolanta Lissowska, Jan Lubiński, Galina Lurie, Valerie McGuire, John McLaughlin, Krzysztof Mędrek, Patricia G Moorman, Kirsten Moysich, Steven Narod, Catherine Phelan, Carole Pye, Harvey Risch, Ingo B Runnebaum, Gianluca Severi, Melissa Southey, Daniel O Stram, Falk C Thiel, Kathryn L Terry, Ya-Yu Tsai, Shelley S Tworoger, David J Van Den Berg, Robert A Vierkant, Shan Wang-Gohrke, Penelope M Webb, Lynne R Wilkens, Anna H Wu, Hannah Yang, Wendy Brewster, Argyrios Ziogas, Richard Houlston, Ian Tomlinson, Alice S Whittemore, Mary Anne Rossing, Bruce A J Ponder, Celeste Leigh Pearce, Roberta B Ness, Usha Menon, Susanne Krüger Kjaer, Jacek Gronwald, Montserrat Garcia-Closas, Peter A Fasching, Douglas F Easton, Georgia Chenevix-Trench, Andrew Berchuck, Paul D P Pharoah, Simon A Gayther
Institutions: QIMR Berghofer Medical Research Institute, University of Cambridge, Peter MacCallum Cancer Centre, Cancer Research UK, University College London, Division of Cancer Epidemiology and Genetics, University of California, Irvine, German Cancer Research Center, Brigham and Women's Hospital, Medizinische Hochschule Hannover, Mayo Clinic, University of Hawaiʻi at Mānoa, University of Hawaii System, Duke Medical Center, Moffitt Cancer Center, Cancer Council Victoria, Universitätsklinikum Erlangen, The University of Melbourne, Aarhus University Hospital, Fred Hutch Cancer Center, Jena University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Royal Marsden Hospital, Harvard University, Rigshospitalet, Danish Cancer Society, Duke University, International Hereditary Cancer Center, Pomeranian Medical University, The Maria Sklodowska-Curie National Research Institute of Oncology, Stanford Medicine, Stanford University, Lunenfeld-Tanenbaum Research Institute, Roswell Park Comprehensive Cancer Center, Yale University, University of Southern California, Universität Ulm, University of North Carolina at Chapel Hill, Institute of Cancer Research, Centre for Human Genetics, The University of Texas Health Science Center at Houston, University of California, Los Angeles
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Ovarian Cancer Research Fund, Mayo Foundation for Medical Education and Research, Kræftens Bekæmpelse, Wellcome Trust, Lon V. Smith Foundation, Cancer Research UK, National Institute for Health and Care Research, Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe, University College London Hospitals NHS Foundation Trust, Universität Ulm, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, Cancer Council Tasmania, National Cancer Institute
Awards: G1335914152, G1355612696, G1440585907, Towards cancer control: Population and molecular strategies, G156582752, RISK FACTORS AND PROGNOSTIC FACTORS FOR OVARIAN CANCER, G1675456475, G168441794, G1791794685, G1972180448, Steroid Hormone Genes and Ovarian Cancer Risk, G2342347956, HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES, G2833979660, Hereditary Breast Cancer: Genetic and Molecular Studies, Genes, Hormones & Environment in an Ovarian Cancer Model, G3205575695, G348073316, G3695179805, SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER), WS No. 12 Patterns of Care DX Year 2008, G4638184864, Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE, G5277962741, Collaborative Genetic Study of Ovarian Cancer Risk, G544810358, G5496469482, Epidemiology of Ovarian Cancer:New Hypotheses, G5865683244, G6208597191, G6279653796, G6283257732, G6466116822, G667355291, Hormonal Factors in Invasive and LMP Ovarian Cancers, G7009610138, G7367186041, Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology, G764070827, G7989612811, G8085000608, G8386849510, G847461785, Haplotype-Based Genome Screen for Ovarian Cancer Loci, G884846590, Roswell Park Cancer Center Support Grant, Mayo Clinic Ovarian Cancer SPORE
OpenAlex ID: W2137186819
